n.d.: not determined. ?: not clear (a) Line 3D6—includes mutation of SHP2 tyrosine phosphatase; (b) nestin-tTA mouse crossed with tetracycline regulated CREB used as readout; (c) Okada et al., 1999; (d) shown in vitro; (e) nestin expressed in the same general areas as transgene, cell coexpression not determined; (f) tested postnatally; (g) BrdU labeling index not changed, colabelling with transgene not done; (h) embryonically in vivo and in vitro; (i) parenchymal GFP+ cells visible in Figure 1(g); (j) SVZ but not dentate gyrus; (k) as determined by BrdU retention; (l) S 100b-labelling in Figure 4(a) looks ependymal not astrocytic; (m) determined by lack of BrdU pulse labelling; (n) glial morphology; (o) not labelled with BrdU; (p) not within 6 hrs post-MCAo; (q) embryonically, self-renewal and multipotency shown; (r) postnataly, self-renewal and multipotency shown.
